Search research articles
Contact Us
Filters
Showing results (31-40 of 391) with videos related to
Page
of 40
Sort By:
The Medical Clinics of North America
|
March 28, 2024
Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long?
Khawaja Hassan Akhtar, Usman Baber
JACC. Cardiovascular Interventions
|
September 20, 2020
Duration of Dual Antiplatelet Therapy After PCI: How Short Can We Go?
Usman Baber, Dominick J Angiolillo
Journal of the American College of Cardiology
|
December 8, 2018
Left Main PCI With DES Versus CABG: Cautionary Note or Cause for Concern?
Usman Baber, George D Dangas
Journal of the American College of Cardiology
|
August 29, 2015
The Shifting Pendulum for DAPT After PCI: Balancing Long-Term Risks for Bleeding and Thrombosis
Samin K Sharma, Usman Baber
Circulation
|
November 6, 2012
Exercise physiology in the catheterization laboratory: still alive and well!
Usman Baber, George D Dangas
Interventional Cardiology Clinics
|
September 14, 2020
The Role of Aspirin After High-Risk Percutaneous Coronary Intervention: The Ticagrelor with Aspirin or Alone in High-Risk Patients After Coronary Intervention Clinical Trial Experience
Zain Ul Abideen Asad, Usman Baber
JACC. Cardiovascular Interventions
|
November 25, 2017
Reply: Research and Therapeutic Nihilisms in Chronic Kidney Disease
Usman Baber, Jaya Chandrasekhar, Roxana Mehran
JACC. Cardiovascular Interventions
|
August 24, 2019
Reply: DAPT Cessation and MACE in Elderly Patients: What Is the Optimal Regimen and Duration?
Lauren Joyce, Usman Baber, Roxana Mehran
Nature Reviews. Cardiology
|
December 3, 2014
Balancing ischaemia and bleeding risks with novel oral anticoagulants
Usman Baber, Ioannis Mastoris, Roxana Mehran
US Cardiology
|
December 25, 2024
TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention
Johny Nicolas, Usman Baber, Roxana Mehran
Page
of 40
Search research articles
Search
Showing results (31-40 of 391) with videos related to
Sort By:
Page
of 40
The Medical Clinics of North America
|
March 28, 2024
Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long?
Khawaja Hassan Akhtar, Usman Baber
JACC. Cardiovascular Interventions
|
September 20, 2020
Duration of Dual Antiplatelet Therapy After PCI: How Short Can We Go?
Usman Baber, Dominick J Angiolillo
Journal of the American College of Cardiology
|
December 8, 2018
Left Main PCI With DES Versus CABG: Cautionary Note or Cause for Concern?
Usman Baber, George D Dangas
Journal of the American College of Cardiology
|
August 29, 2015
The Shifting Pendulum for DAPT After PCI: Balancing Long-Term Risks for Bleeding and Thrombosis
Samin K Sharma, Usman Baber
Circulation
|
November 6, 2012
Exercise physiology in the catheterization laboratory: still alive and well!
Usman Baber, George D Dangas
Interventional Cardiology Clinics
|
September 14, 2020
The Role of Aspirin After High-Risk Percutaneous Coronary Intervention: The Ticagrelor with Aspirin or Alone in High-Risk Patients After Coronary Intervention Clinical Trial Experience
Zain Ul Abideen Asad, Usman Baber
JACC. Cardiovascular Interventions
|
November 25, 2017
Reply: Research and Therapeutic Nihilisms in Chronic Kidney Disease
Usman Baber, Jaya Chandrasekhar, Roxana Mehran
JACC. Cardiovascular Interventions
|
August 24, 2019
Reply: DAPT Cessation and MACE in Elderly Patients: What Is the Optimal Regimen and Duration?
Lauren Joyce, Usman Baber, Roxana Mehran
Nature Reviews. Cardiology
|
December 3, 2014
Balancing ischaemia and bleeding risks with novel oral anticoagulants
Usman Baber, Ioannis Mastoris, Roxana Mehran
US Cardiology
|
December 25, 2024
TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention
Johny Nicolas, Usman Baber, Roxana Mehran
Page
of 40